Unexplained international differences in clinical outcomes after acute myocardial infarction and fibrinolytic therapy: Lessons from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial
R. John Simes, Rachel L. O'Connell, Philip E. Aylward, Sergei Varshavsky, Rafael Diaz, Robert G. Wilcox, Paul W. Armstrong, Christopher B. Granger, John K. French, Frans Van de Werf, Ian C. Marschner,Volume:
159
Year:
2010
Language:
english
Pages:
998
DOI:
10.1016/j.ahj.2009.12.044
File:
PDF, 403 KB
english, 2010